Surgical Modalities in Management of Vitiligo

Chapter
Part of the Updates in Clinical Dermatology book series (UCD)

Abstract

Vitiligo is a common condition characterized by hypopigmented and/or depigmented spots on the skin, affecting approximately 1–2% of the world population. Until about 30 years ago, it was exclusively treated with medical therapies. Most commonly used medical therapies include topical steroids, calcineurin inhibitors, and phototherapy. Lesions on the face and neck respond the best to the medical therapies, followed by proximal extremities and trunk, while those distributed over acral parts of extremities and non-hairy areas such as wrist, feet, and male genitals respond poorly. Surgical methods complement medical therapies by providing melanocytes to these refractory lesions and are indicated for unilateral segmental and clinically stable bilateral vitiligo, refractory to medical treatment. Tissue grafting methods include minigrafting or punch grafting, epidermal grafting, and split-thickness grafting. These methods use full-thickness punch grafts, roof of epidermal blisters, and shave biopsy samples, respectively, as the source of melanocytes. Cellular grafting includes non-cultured and cultured melanocyte/keratinocyte suspensions obtained from trypsinizing the shaved skin biopsy sample as a source of melanocytes. Recent advances over the years have enabled the dermatologists to treat extensive areas located on many anatomic sites, in a single operative session by surgical intervention. The purpose of this review is to describe the selection criteria for the surgical treatment, their utility, and limitations in various types of vitiligo.

Keywords

Cellular graftingPunch grafting Non cultured melanocytes Vitiligo surgery Vitiligo treatment 

References

  1. 1.
    Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo global issues consensus conference. Pigment Cell Melanoma Res. 2012;25:E1–E13.CrossRefGoogle Scholar
  2. 2.
    Hann SK, Lee JH. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol. 1996;35:671–4.CrossRefGoogle Scholar
  3. 3.
    Falabella R. Vitiligo and melanocyte reservoir. Indian J Dermatol. 2009;54:313–8.CrossRefGoogle Scholar
  4. 4.
    Behl PN. Treatment of vitiligo with homologous thin Thiersch’s skin grafts. Curr Med Pract. 1964;8:218–21.Google Scholar
  5. 5.
    Behl PN, Bhatia RK. Treatment of vitiligo with autologous thin Thiersch’s graft. Int J Dermatol. 1973;12:329–31.CrossRefGoogle Scholar
  6. 6.
    Falabella R. Repigmentation of segmental vitiligo by autologous minigrafting. J Am Acad Dermatol. 1983;9:514–21.CrossRefGoogle Scholar
  7. 7.
    Falabella R, Barona MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res. 2008;22:42–65.CrossRefGoogle Scholar
  8. 8.
    Mutalik S, Ginzberg A. Surgical management of stable vitiligo: a review with personal experience. Dermatol Surg. 2000;26:248–54.CrossRefGoogle Scholar
  9. 9.
    Savant SS. Autologous miniature punch skin grafting in stable vitiligo. Indian J Dermatol Venereol Leprol. 1992;58:310–4.Google Scholar
  10. 10.
    Boersma B, Westerhof W, Bos JD. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol. 1995;33:990–5.CrossRefGoogle Scholar
  11. 11.
    Falabella R. Treatment of localized vitiligo by autologous Minigrafting. Arch Dermatol. 1988;124:1649–55.CrossRefGoogle Scholar
  12. 12.
    Malakar S, Dhar S. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1000 patients. Dermatology. 1999;198:133–9.CrossRefGoogle Scholar
  13. 13.
    Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guidelines for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051–76.CrossRefGoogle Scholar
  14. 14.
    Kistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol. 1968;50:129–37.CrossRefGoogle Scholar
  15. 15.
    Falabella R. Epidermal grafting. An original technique and its application in achromic and granulating areas. Arch Dermatol. 1971;104:592–600.CrossRefGoogle Scholar
  16. 16.
    Falabella R. Repigmentation of leukoderma by autologous epidermal grafting. J Dermatol Surg Oncol. 1984;10:136–44.CrossRefGoogle Scholar
  17. 17.
    Koga M. Epidermal grafting using the tops of suction blisters in the treatment of vitiligo. Arch Dermatol. 1988;124:1656–8.CrossRefGoogle Scholar
  18. 18.
    Mutalik S. Transplantation of melanocytes by epidermal grafting- an Indian experience. J Dermatol Surg Oncol. 1993;19:231–4.CrossRefGoogle Scholar
  19. 19.
    Gupta S, Shroff S. Modified technique of suction blistering for epidermal grafting in vitiligo. Int J Dermatol. 1999;38:306–9.CrossRefGoogle Scholar
  20. 20.
    Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol. 2003;104:99–104.CrossRefGoogle Scholar
  21. 21.
    Kahn AM, Cohen MJ. Vitiligo: treated by dermabrasion and epithelial sheet grafting. J Am Acad Deramatol. 1995;33:646–8.CrossRefGoogle Scholar
  22. 22.
    Kahn AM, Cohen MJ. Repigmentation in vitiligo patients. Dermatol Surg. 1998;24:365–7.PubMedGoogle Scholar
  23. 23.
    Agarwal K, Agarwal A. Vitiligo: repigmentation with dermabrasion and thin split-thickness skin grafts. Dermatol Surg. 1995;43:273–4.Google Scholar
  24. 24.
    Njoo MD, Westerhof W, Bos JD, Bossuyt PMM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol. 1998;134:1343–9.Google Scholar
  25. 25.
    Falabella R. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol. 1989;21:257–64.CrossRefGoogle Scholar
  26. 26.
    Olsson MJ, Juhlin L. Repigmentation of vitiligo by transplantation of cultured autologous melanocytes. Acta Derm Venereol. 1993;73:49–51.PubMedGoogle Scholar
  27. 27.
    Chen YF, Yang PY, Treatment HDN. Of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol. 2004;51:68–74.CrossRefGoogle Scholar
  28. 28.
    Pianigiani E, Risulo M, Andrea A, Paolo T, Francesca I, Lucio A. Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo. Dermatol Surg. 2005;31:155–9.CrossRefGoogle Scholar
  29. 29.
    Gauthier Y, Surleve-Bazeille J-E. Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol. 1992;26:191–4.CrossRefGoogle Scholar
  30. 30.
    Olsson MJ, Juhlin L. Leucoderma treated by transplantation of a basal layer enriched suspension. Br J Dermatol. 1998;138:644–8.CrossRefGoogle Scholar
  31. 31.
    Mulekar SV. Long-term follow-up study of segmental and focal Vitiligo treated by autologous non-cultured melanocyte-keratinocyte cell transplantation. Arch Dermatol. 2004;140:1213–5.CrossRefGoogle Scholar
  32. 32.
    Mulekar SV, Ghwish B, Al Issa A, Al Eisa A. Treatment of vitiligo lesions by ReCell vs conventional melanocyte-keratinocyte transplantation: a pilot study. Br J Dermatol. 2008;158:45–9.PubMedGoogle Scholar
  33. 33.
    Van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg. 2001;27:873–6.PubMedGoogle Scholar
  34. 34.
    Budania A, Prasad D, Kanwar AJ, Dogra S. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. Br J Dermatol. 2012;167:1295–301.CrossRefGoogle Scholar
  35. 35.
    Mohanty S, Kumar A, Dhawan J, Sreenivas V, Gupta S. Extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo. Br J Dermatol. 2011;164:1241–6.CrossRefGoogle Scholar
  36. 36.
    Singh C, Prasad D, Kanwar AJ, et al. Comparison between autologous noncultured extracted outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo. Br J Dermatol. 2013;169:287–93.CrossRefGoogle Scholar
  37. 37.
    Gupta S, Kumar A, Mahendra A, Gupta SA. Minimally invasive scarless technique of donor tissue harvesting for noncultured epidermal cell suspension transplantation in vitiligo. J Am Acad Dermatol. 2015;73:e213–5.CrossRefGoogle Scholar
  38. 38.
    Mulekar SV. Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int J Dermatol. 2003;42:132–6.CrossRefGoogle Scholar
  39. 39.
    Chen YF, Chang JS, Yang PY, Hung CM, Huang MH, Transplant HDN. Of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental Vitiligo. J Dermatol. 2000;27:434–9.CrossRefGoogle Scholar
  40. 40.
    Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, et al. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol. 2003;139:1303–10.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.National Center for Vitiligo & PsoriasisRiyadhSaudi Arabia

Personalised recommendations